Neural modelling today. Neural repair tomorrow.
Standardised cortical organoids, built for genome-linked cohorts rather than single lines.
Neural modelling today.
What a cortical organoid is
A three-dimensional structure grown from pluripotent cells that self-organises into layered neural tissue, with the radial arrangement of progenitors around a lumen that characterises early cortical development. It is a model of developing tissue, not a brain, and we are precise about that distinction because the difference matters scientifically and ethically.
What it is used for
Research applications in neurodegeneration, neurodevelopmental conditions, neurotoxicity and central nervous system discovery. Human tissue answers questions that animal models answer imperfectly, because the biology being modelled is human.
Why cohorts beat single lines
A result from one line is a result from one genome. A result across a cohort of characterised, genome-linked lines is a result about variation, which is what precision medicine actually needs.
Reproducibility
Organoid work has a reputation for variability. Bioreactor conditions, cell density, timing and QC at every step are what turn a demonstration into a platform, and that engineering is where most of the effort goes.
Blood–brain barrier model
A blood–brain barrier co-culture alongside cortical organoids, to study whether a compound reaches neural tissue at all. Penetration is a standing question in CNS drug development and one a human model can answer earlier.
Generation of cortical organoids from iPSC lines is a published, reproducible technique.
Standardisation, QC, cohort-scale production and a blood–brain barrier co-culture.
Neural repair. This is a long-term goal and not a treatment we offer.